Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMay 1, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 23, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 23, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 12, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 28, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 20, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 20, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 8, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 6, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 6, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 26, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 21, 2013View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 15, 2013View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 14, 2013View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 14, 2013View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 14, 2013View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 14, 2013View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-116

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information